Published on 8 Oct 2021 on Benzinga via Yahoo Finance
28 Stocks Moving In Friday's Mid-Day Session
Gainers
ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-associated vasculitis (ANCA-associated vasculitis or ANCA vasculitis).Renren Inc. (NYSE: RENN) jumped 40.9% to $23.40. Renren, last month, named Chris Palmer as its Chief Financial Officer.ReShape Lifesciences Inc. (NASDAQ: RSLS) shares climbed 28.2% to $3.18. Maxim Group initiated coverage on Reshape Lifesciences with a Buy rating and announced a price target of $8.Camber Energy, Inc.. (NYSE: CEI) jumped 26.5% to $2.2510 after jumping around 96% on Thursday.Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 17.7% to $3.73.Altisource Portfolio Solutions S.A. (NASDAQ: ASPS) surged 16.6% to $13.70. The company recently agreed to sell Pointillist subsidiary for $150 million.Aehr Test Systems (NASDAQ: AEHR) gained 14.4% to $19.05. Craig-Hallum raised the price target on Aehr Test Systems to $31 from $12, implying an 86.1% upside, and reiterated a Buy.Repare Therapeutics Inc. (NASDAQ: RPTX) jumped 13.5% to $24.85. Repare Therapeutics issued statement regarding inadvertent issuance of Phase 1/2 TRESR RP-3500 clinical trial abstract by AACR-NCI-EORTC Virtual International Conference.DatChat, Inc. (NASDAQ: DATS) shares rose 11.4% to $8.96 after gaining over 9% on Thursday.Cue Health Inc. (NASDAQ: HLTH) gained 9.4% to $11.82.Momentive Global Inc. (NASDAQ: MNTV) rose 9.3% to $23.64. Momentive Global is weighing options, including a potential sale after receiving takeover interest, Bloomberg reported.eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 9.1% to $12.52 after the company, in collaboration with investigators at Baylor College of Medicine, announced the presentation of new data for zotatifin in animal models of triple-negative breast cancer at the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.Sundial Growers Inc. (NASDAQ: SNDL) rose 8% to $0.70 after the company announced plans to acquire Alcanna for total consideration of approximately $346 million.Immuron Limited (NASDAQ: IMRN) rose 5.7% to $3.72 as the company announced a recent publication of antiviral data from the IMM-124E preclinical and Phase 1/2a trials.